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Abstract
Introduction: Both sugar-sweetened beverage (SSB) intake and body mass index (BMI) are associated with elevated
serum urate concentrations and gout risk. The aim of this study was to determine whether the associations of SSB
intake with serum urate and gout are moderated by BMI.
Method: The effects of chronic SSB intake on serum urate and gout status were analysed in a large cross-sectional
population study. The effects of an acute fructose load on serum urate and fractional excretion of uric acid (FEUA)
were examined over 180 minutes in a short-term intervention study. In all analyses, the responses were compared
in those with BMI <25 mg/kg2 (low BMI) and ≥25 mg/kg2 (high BMI).
Results: In the serum urate analysis (n = 12,870), chronic SSB intake was associated with increased serum urate in
the high BMI group, but not in the low BMI group (Pdifference = 3.6 × 10
−3). In the gout analysis (n = 2578), chronic
high SSB intake was associated with gout in the high BMI group, but not in the low BMI group (Pdifference = 0.012).
In the acute fructose loading study (n = 76), serum urate was increased in the high BMI group at baseline and
throughout the observation period (PBMI group <0.0001), but there were similar acute serum urate increases in both
BMI groups in response to the fructose load (Pinteraction = 0.99). The baseline FEUA was similar between the two BMI
groups. However, following the fructose load, FEUA responses in the BMI groups differed (Pinteraction <0.0001), with
increased FEUA at 120 minutes and 180 minutes in the low BMI group and reduced FEUA at 60 minutes in the
high BMI group.
Conclusions: These data suggest that BMI influences serum urate and gout risk in response to chronic SSB intake,
and renal tubular uric acid handling in response to an acute fructose load. In addition to many other health benefits,
avoidance of SSBs may be particularly important in those with overweight/obesity to prevent hyperuricaemia and
reduce gout risk.
Trials registration: Australian Clinical Trials Registry ACTRN12610001036000. Registered 24 November 2010.
Introduction
Serum urate concentrations are influenced by a number
of modifiable and non-modifiable factors. Intake of
sugar-sweetened beverages is a strong modifiable risk
factor for hyperuricaemia and gout [1–4]. The effect of
sugar-sweetened beverage intake on serum urate has
been attributed to the hepatic effects of fructose on
adenosine triphosphate degradation, which in turn, in-
duces urate production [5]. Sugar may also directly
interfere with urate excretion via the hexose-uric acid
transporter solute carrier family 2, facilitated glucose
transporter member 9 (SLC2A9) [4].
Elevated body mass index is another modifiable risk
factor for hyperuricaemia and development of gout [6],
with a consistent strong relationship between central
adiposity and serum urate [7], which may be mediated
by the effects of insulin on renal tubular uric acid re-
absorption [8]. There are accumulating data that body
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mass index can modulate the influence of non-
modifiable genetic variants on serum urate [9, 10]. The
influence of body mass index may also modulate associ-
ations of modifiable factors, such as sugar-sweetened
beverage intake, with serum urate and gout. The aim of
this study was to determine whether the associations be-
tween sugar-sweetened beverage intake with serum urate
and gout are moderated by body mass index.
Methods
We addressed the study aim in two separate analyses:
first, in a large cross-sectional population study exa-
mining the effects of chronic sugar-sweetened beverage
intake on serum urate and gout, and second, in a short-
term intervention study examining the effects of an
acute fructose load on serum urate and fractional excre-
tion of uric acid. In all analyses, the responses were ana-
lysed in those with body mass index <25 mg/kg2 (low
body mass index group) and those with body mass
index ≥ 25 mg/kg2 (high body mass index group).
Chronic sugar-sweetened beverage intake serum urate
analysis
The effect of chronic sugar-sweetened beverage intake on
serum urate in separate body mass index strata was
assessed by analysing 12,870 people without gout from the
Atherosclerosis Risk in Communities (ARIC), Framingham
Heart Study (FHS) and New Zealand (NZ) datasets. The
ARIC (n = 8,436) and FHS (n = 3,066) cohorts are US lon-
gitudinal studies described by us elsewhere [11] whereas
the NZ dataset is a cross-sectional sample set recruited
from 2007 to 2014 [4]. The FHS Generation 3 cohort was
analysed with all measures taken at examination 1 (2002–
2005) and all ARIC measures were taken at examination 1
(1987–1989). Sugar-sweetened beverage consumption was
assigned to one of three categories – those drinking no
sugar-sweetened beverages (no sugar-sweetened beverage
intake group), >0 to <2 sugar-sweetened beverages per day
(low sugar-sweetened beverage intake group) and ≥2
sugar-sweetened beverages per day (high sugar-sweetened
beverage intake group). Serum urate was regressed against
the three categories in body mass index <25 mg/kg2, body
mass index ≥25 mg/kg2 and unstratified. All analyses were
adjusted by ethnicity, age, sex, fruit intake, triglycerides,
kidney disease (self-reported) and hypertension, and re-
latedness in FHS. Significant difference in the change in
serum urate per sugar-sweetened beverage category be-
tween body mass index groups was assessed by calculating
a Cochran’s Q test statistic and the corresponding P value
(PQ). Data were analysed using STATA version 13.1
(StataCorp, College Station, TX, USA) and R 3.0.2 in
the RStudio GUI version 0.98.1087 (R Foundation for
Statistical Computing, Vienna, Austria).
Chronic sugar-sweetened beverage intake gout analysis
The effect of chronic sugar-sweetened beverage intake
on gout status in separate body mass index strata was
assessed by analysing 2,578 people (n = 1,368 without
gout and 1,210 with gout) from the NZ dataset [4]. Gout
was clinically ascertained using the 1977 American
Rheumatism Association preliminary gout classi-
fication criteria [12]. A logistic regression of sugar-
sweetened beverage intake (based on the three categories:
0, >0 to <2, >2) with gout status was performed to deter-
mine the odds ratio for gout. All analyses were adjusted
by ethnicity, age, sex, fruit intake, triglycerides, kidney
disease and hypertension. Significant difference in the
odds ratios for gout per sugar-sweetened beverage cat-
egory between body mass index groups was assessed by
calculating a Cochran’s Q test statistic and the cor-
responding P value (PQ). Data were analysed using
STATA version 13.1 and R 3.0.2 in the RStudio GUI
version 0.98.1087.
Acute fructose intake analysis
The methods of the acute fructose intake study have
been previously reported [13]. Exclusion criteria were:
gout, diabetes mellitus or fructose intolerance, diuretic
use, fasting glucose >6 mmol/L. Following an overnight
fast, 76 healthy volunteers consumed a sugar solution
between 8 a.m. and 9 a.m., and blood was obtained prior
to ingestion and then 30 minutes, 60 minutes, 120 mi-
nutes, and 180 minutes after ingestion. Urine was ob-
tained at each time point for testing of urate and
creatinine to allow calculation of fractional excretion of
uric acid (uric acid clearance/creatinine clearance ex-
pressed as a percentage). Weight and height were mea-
sured at the start of the study visit, and body mass index
was calculated. The sugar solution of 300 kcal/300 ml
was consumed within 10 minutes, according to the
protocol of Akhavan and Anderson for fructose-induced
hyperuricaemia [14]. This solution contained 80 % fruc-
tose and 20 % glucose (64 g fructose and 16 g glucose).
The study was approved by the New Zealand Multire-
gional Ethics Committee, and each participant gave writ-
ten informed consent.
Data were analysed using a mixed models approach to
repeated measures. Significant main and interaction
effects were explored using the method of Tukey. Sex,
ethnicity and triglycerides were adjusted for within the
models. For change in serum urate and other biochem-
ical variables, a mixed models analysis of covariance
(ANCOVA) approach to repeated measures was used.
For ANCOVA, the dependent variable was change from
baseline, and baseline level was included as a covariate.
Analyses were performed using SAS v 9.2 (SAS Institute
Inc., Cary, NC, USA). P <0.05 was considered significant
and all tests were two-tailed.
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Results
Chronic sugar-sweetened beverage intake and
serum urate
The characteristics of participants in the chronic sugar-
sweetened beverage intake and serum urate analysis are
shown in Table 1. The majority of participants were of
Caucasian ethnicity (n = 10,443), with smaller numbers
of participants of New Zealand Polynesian (n = 918) and
African American (n = 1,509) ethnicity. More than half
(61.1 %) of participants had a body mass index ≥25 kg/m2.
The mean sugar-sweetened beverage intake in the low
body mass index group was 1.1 drinks/day and in the high
body mass index group was 1.2 drinks/day. Serum urate
was higher in the high body mass index group compared
to the low body mass index group.
In this analysis, high sugar-sweetened beverage intake
was associated with higher serum urate in the entire
group (compared with no sugar-sweetened beverage
intake, body mass index-adjusted P = 0.11 for low sugar-
sweetened beverage intake and P = 1.9 × 10−3 for high
sugar-sweetened beverage intake, Table 2). There was
no association between sugar-sweetened beverage in-
take and serum urate in the low body mass index group
(P = 0.20 for low sugar-sweetened beverage intake and
P = 0.67 for high sugar-sweetened beverage intake). In
contrast, increased sugar-sweetened beverage intake
was associated with higher serum urate in the high
body mass index group (P = 9.4 × 10−4 for low sugar-
sweetened beverage intake and P = 7.2 × 10−6 for high
sugar-sweetened beverage intake). The difference in
serum urate according the sugar-sweetened beverage
categories was significantly greater in the high body
mass index group than in the low body mass index
group (Pdifference = 3.6 × 10
−3). The difference in serum
urate was higher in the high body mass index group for
both low sugar-sweetened beverage intake (Pdifference =
1.4 × 10−3) and high sugar-sweetened beverage intake
(Pdifference = 9.3 × 10
−4).
Chronic sugar-sweetened beverage intake and
gout status
The characteristics of participants in the chronic sugar-
sweetened beverage intake and gout analysis are shown
in Table 3. The majority of participants with gout
(76.8 %) were on urate-lowering therapy. There were dif-
ferences between cases and controls with respect to sex,
age, ethnicity, serum urate, triglycerides, body mass
index, and history of hypertension and kidney disease
(Table 3).
In the low body mass index group, after adjustment
for all these variables, low sugar-sweetened beverage in-
take was associated with a reduced odds ratio (OR) for
gout (OR 0.43, P = 0.043) compared to no intake, and
there was no increase in the odds ratio for high sugar-
sweetened beverage intake (OR 0.64, P = 0.31) (Table 4).
In contrast, high sugar-sweetened beverage intake was
associated with a higher odds ratio for gout (OR 1.33,
P = 0.033) in the high body mass index group. The
Table 1 Clinical features of all participants in the chronic sugar-sweetened beverage intake urate analysis







Age, years 100 49.5 (10.1) 48.9 (10.4) 49.9 (9.9) 9 × 10−9*
Male sex, n (%) 100 6030 (46.9) 1740 (34.8) 4288 (54.5) <1.0 × 10−5**
NZ East Polynesian dataset, n (%) 100 583 (4.5) 96 (1.9) 487 (6.2) <1.0 × 10−5**
NZ West Polynesian dataset, n (%) 100 271 (2.1) 16 (0.3) 255 (3.2)
NZ Mixed East/West Polynesian dataset, n (%) 100 64 (0.5) 4 (0.1) 60 (0.8)
NZ Caucasian dataset, n (%) 100 450 (3.5) 152 (3.0) 298 (3.8)
ARIC Caucasian dataset, n (%) 100 6927 (53.8) 2930 (58.6) 3996 (50.8)
FHS Caucasian dataset, n (%) 100 3066 (23.8) 1380 (27.6) 1686 (21.4)
ARIC African American dataset, n (%) 100 1509 (11.7) 424 (8.5) 1080 (13.7)
Serum urate, mmol/L 98.4 0.33 (0.09) 0.30 (0.07) 0.36 (0.08) <1.0 × 10−300*
Triglycerides, mmol/L 98.0 1.79 (1.52) 1.45 (1.04) 2.01 (1.72) <1.0 × 10−300*
Body mass index, kg/m2 99.9 27.1 (5.4) 22.4 (1.8) 30.1 (4.8) <1.0 × 10−300*
Fruit intake, pieces/day 99.8 1.47 (1.31) 1.45 (1.32) 1.48 (1.31) 0.32*
Kidney disease, n (%) 96.3 134 (1.1) 34 (0.7) 100 (1.3) 1.4 × 10−3**
Hypertension, n (%) 99.3 1541 (12.1) 395 (7.9) 1143 (14.7) <1.0 × 10−5**
Unless specified, data are presented as mean (SD)
BMI body mass index, NZ New Zealand, ARIC Atherosclerosis Risk in Communities, FHS Framingham Heart Study
*Two-sample t test with unequal variances
**Chi-square test
Dalbeth et al. Arthritis Research & Therapy  (2015) 17:263 Page 3 of 7
odds ratios according to the sugar-sweetened beverage
categories were significantly greater in the high body mass
index group than in the low body mass index group
(Pdifference = 0.012). The difference in the odds ratios for
gout were significantly different between the body mass
index groups for both low sugar-sweetened beverage in-
take (Pdifference = 5.9 × 10
−4) and high sugar-sweetened
beverage intake (Pdifference = 0.028).
Acute fructose intake
The characteristics of participants in the acute fructose in-
take analysis are shown in Table 5. As previously reported,
the study participants were of European (n = 25), Māori
(n = 25) and Pacific (n = 26) ethnicity. More than half
(59 %) of participants had a body mass index ≥25 kg/m2.
There were fewer European and more Pacific participants
in the high body mass index group. All analyses were ad-
justed for sex and ethnicity.
In the acute fructose feeding study, serum urate
was higher in the high body mass index group at
baseline and throughout the observation period
(Fig. 1a, Pbody mass index group <0.0001). There were
similar acute serum urate increases in both body
mass index groups in response to the fructose load
Table 2 Difference in serum urate concentration for chronic sugar-sweetened beverage intake stratified by body mass index (BMI) group
Per SSB category Overall SSB category
SSB drinks/day Δ in serum urate,
95 % CI (mmol/L)
P** Δ in serum urate,
95 % CI (mmol/L)
P Pdifference between
BMI <25 and ≥25
All participants (n = 12,081)* 0 - - 0.004 (0.002–0.006) 9.7 × 10−4 -
>0 to <2 0.004 (0.000–0.008) 0.11
≥2 0.009 (0.005–0.014) 1.9 × 10−3
BMI <25 (n = 4,731) 0 - - −0.000 (−0.004– 0.003) 0.97 3.6 × 10−3
>0 to <2 −0.004 (−0.010–0.002)† 0.20
≥2 −0.002 (−0.009–0.006)†† 0.67
BMI ≥25 (n = 7, 350) 0 - - 0.007 (0.004–0.010) 1.4 × 10−5
>0 to <2 0.010 (0.004–0.015)† 9.4 × 10−4
≥2 0.015 (0.008–0.021)†† 7.2 × 10−6
The difference in serum urate in the overall sugar-sweetened beverage (SSB) category is the average difference from sugar-sweetened beverage category 1 to
category 2 to category 3 (i.e. 0, to >0 to <2, to ≥2). All analysis adjusted by sample set (Atherosclerosis Risk in Communities (ARIC) Caucasian, Framingham Heart
Study (FHS) Caucasian, New Zealand (NZ) Caucasian, East Polynesian, West Polynesian, Mixed East Polynesian/West Polynesian, ARIC African American), age, sex,
fruit intake (continuous variable), kidney disease, hypertension, triglycerides, and relatedness
*Analysis adjusted by BMI
**Compared with referent group (0 SSB/day)
†Pdifference between BMI groups =1.4 × 10
−3
††Pdifference between BMI groups = 9.3 × 10
−4
Table 3 Clinical features of participants in the gout analysis







Age, years 100 52.1 (16.4) 47.0 (16.5) 57.8 (14.4) 4.9 × 10−66*
Male sex, n (%) 100 1739 (67.5) 740 (54.1) 999 (82.6) <1.0 × 10−5**
NZ East Polynesian dataset, n (%) 100 901 (35.0) 583 (42.6) 319 (26.4) <1.0 × 10−5**
NZ West Polynesian dataset, n (%) 100 597 (23.2) 271 (19.8) 326 (26.9)
NZ Mixed East/West Polynesian dataset, n (%) 100 92 (3.6) 64 (4.7) 28 (2.3)
NZ Caucasian dataset, n (%) 100 987 (38.3) 450 (32.9) 537 (44.4)
Serum urate at the time of recruitment, mmol/L 86.5 0.39 (0.11) 0.37 (0.10) 0.43 (0.11) 5.9 × 10−37*
Triglycerides, mmol/L 86.9 2.14 (1.4) 1.93 (1.18) 2.39 (1.60) 2.3 × 10−14*
Body mass index, kg/m2 100 32.4 (7.6) 31.3 (7.5) 33.6 (7.6) 2.6 × 10−15*
Fruit intake, pieces/day 98.9 2.9 (4.6) 2.8 (4.2) 3.0 (5.0) 0.27*
Kidney disease, n (%) 98.0 295 (11.7) 57 (4.3) 238 (20.1) <1.0 × 10−5**
Hypertension, n (%) 98.3 975 (38.5) 309 (23.0) 666 (55.9) <1.0 × 10−5**
Unless specified, data are presented as mean (SD)
NZ New Zealand
*Two-sample t test with unequal variances
**Chi-square test
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(Fig. 1b, Pinteraction = 0.99). The fractional excretion of
uric acid was similar between the two body mass
index groups at baseline (Fig. 1c, Tukey-Kramer ad-
justed P = 1.0). The fractional excretion of uric acid
in the low body mass index group increased signifi-
cantly from baseline at 120 minutes and 180 minutes
after the fructose load (Fig. 1c and d, Tukey-Kramer
adjusted P = 0.003 and <0.0001 respectively). In con-
trast, the fractional excretion of uric acid in the high
body mass index group decreased significantly from
baseline at 60 minutes after the fructose load (Fig. 1c
and d, Tukey-Kramer adjusted P = 0.0002), and no
significant increase in fractional excretion of uric acid from
baseline was observed even after 180 minutes of fructose
intake. The fractional excretion of uric acid responses in
the body mass index groups differed significantly following
the fructose load (Fig. 1c and d, Pinteraction <0.0001).
Discussion
This study has shown that body mass index influences
urate homeostasis associated with sugar-sweetened bev-
erage intake. With low body mass index, chronic sugar-
sweetened beverage intake is associated with negligible
difference in serum urate. This may be due to the ability
of the renal tubule to rapidly increase uric acid excretion
following an event that increases serum urate, thus nor-
malising serum concentrations. In contrast, for those
with high body mass index, chronic sugar-sweetened
Table 4 Difference in risk of gout for chronic sugar-sweetened beverage intake stratified by body mass index (BMI) group
Per SSB category Overall SSB category
SSB drinks/day Odds ratio (95 % CI) P** Odds ratio (95 % CI) P Pdifference between BMI <25 and ≥25
All participants (n = 2,144)* 0 - - 1.09 (0.96–1.23) 0.19 -
>0 to <2 0.83 (0.64–1.07) 0.15
≥2 1.20 (0.93–1.54) 0.16
BMI <25 (n = 304) 0 - - 0.74 (0.49–1.13) 0.16 0.012
>0 to <2 0.43 (0.19–0.97)† 0.043
≥2 0.64 (0.28–1.50)†† 0.31
BMI ≥25 (n = 1,840) 0 - - 1.15 (1.01–1.32) 0.035
>0 to <2 0.92 (0.70–1.21)† 0.55
≥2 1.33 (1.02–1.74)†† 0.033
The difference in gout risk in the overall sugar-sweetened beverage (SSB) category is the average difference from sugar-sweetened beverage category 1 to
category 2 to category 3 (i.e. 0, to >0 to <2, to ≥2). All analysis adjusted by age, sex, fruit intake (continuous variable), kidney disease, hypertension, triglycerides,
and ethnicity (New Zealand (NZ) Caucasian, East Polynesian, West Polynesian and Mixed East/West Polynesian)
*Analysis adjusted by BMI
**Compared with referent group (0 SSB/day)
†Pdifference between BMI groups =5.9 × 10
−4
††Pdifference between BMI groups = 0.028
Table 5 Clinical features of participants in the acute fructose loading study
All (n = 76) BMI <25 (n = 31) BMI ≥25 (n = 45) P
Age, years 30 (17) 28 (14) 33 (19) 0.22
Male sex, n (%) 45 (59 %) 15 (48 %) 30 (67 %) 0.18
European ethnicity, n (%) 25 (33 %) 16 (52 %) 9 (20 %) 0.009
Māori ethnicity, n (%) 25 (33 %) 11 (35 %) 14 (31 %) 0.88
Pacific ethnicity, n (%) 26 (34 %) 4 (13 %) 22 (49 %) 0.002
Serum urate, mmol/l 0.36 (0.11) 0.31 (0.09) 0.40 (0.11) 0.0003
Triglycerides, mmol/L 1.24 (0.78) 0.93 (0.34) 1.44 (0.92) 0.0013
Fractional excretion of uric acid, % 5.82 (2.15) 5.97 (2.46) 5.70 (1.97) 0.60
Body mass index, kg/m2 27.4 (5.6) 22.6 (1.66) 30.8 (4.9) <0.0001
Kidney disease, n (%) 1 (1.3 %) 1 (3.2 %) 0 (0 %) 0.82
Hypertension, n (%) 6 (7.9 %) 2 (6.5 %) 4 (8.9 %) 0.99
Unless specified, data are presented as mean (SD)
BMI body mass index
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beverage intake is associated with large increases in
serum urate. With high body mass index, the renal tubu-
lar urate handling response to the acute fructose is
altered, with reduction in fractional excretion of uric
acid and slow renal clearance of uric acid. In the context
of chronic intake of dietary sugar, these renal responses
may lead to prolonged serum urate elevations.
Consistent with the serum urate results, we observed
that high sugar-sweetened beverage intake was associ-
ated with a higher odds ratio for gout in those with high
body mass index, but not in normal weight individuals.
Due to the high use of urate-lowering therapy in partici-
pants with gout, we were unable to determine whether
people with gout and high body mass index have an
amplified serum urate response to sugar-sweetened
beverage intake, compared to normal weight people with
gout. However, our gout analysis does suggest that the
observed serum urate interaction between chronic
sugar-sweetened beverage intake and BMI observed in
the general population is clinically relevant.
In contrast to the in-hospital study by Yamashita et al.
reporting lower fractional excretion of uric acid (FEUA) in
people with obesity compared to normal weight control
participants [15], baseline FEUA were similar between
BMI groups in our acute feeding study, which studied
community-dwelling healthy volunteers. However, acute
FEUA responses were substantially different following the
fructose load. Although higher serum urate was observed
in the high body mass index group throughout the acute
feeding study, we did not observe differences between
body mass index groups in change in serum urate fol-
lowing a fructose load. This is perhaps surprising given
the chronic sugar-sweetened beverage intake study and
the acute fructose study fractional excretion of uric acid
results. These data suggest that the hepatic urate produc-
tion response to an acute fructose load is not influenced
by body mass index. In the context of chronic sugar-
sweetened beverage intake, the ability of the renal tubule
to clear urate following hepatic synthesis may account for
the differential serum urate responses observed between
the chronic and acute study. Unfortunately, there are cur-
rently no large publicly available databases with fractional
excretion of uric acid data to further clarify whether the
renal responses to chronic fructose intake differ between
different body mass index groups. Differential serum urate
responses to acute and chronic sugar-sweetened beverage
intake have been reported previously in relation to genetic
risk factors such as SLC2A9 [4, 13], and it is possible that
chronic sugar-sweetened beverage exposure influences
other pathways that regulate serum urate.
Fig. 1 The effect of body mass index (BMI) group on serum urate and fractional excretion of uric acid (FEUA) during an acute fructose load.
a Serum urate concentration. b Change in serum urate concentration. c FEUA. d Change in FEUA. Data are presented as mean (95 % CI). Sex,
ethnicity and triglyceride-adjusted analysis of covariance (ANCOVA) P values are shown throughout
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Conclusions
Consistent with recent reports showing that body mass
index influences non-modifiable genetic associations
with serum urate [9, 10], this study shows that chronic
sugar-sweetened beverage intake is associated with ele-
vated serum urate and gout status in those with high
body mass index, with minimal effect observed in lean
individuals. In addition to many other health benefits,
avoidance of sugar-sweetened beverages may be particu-
larly important in those with high body mass index to
prevent hyperuricaemia and reduce gout risk.
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